• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对丙型肝炎病毒的适应性免疫。

Adaptive immunity to the hepatitis C virus.

机构信息

Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, USA.

出版信息

Adv Virus Res. 2010;78:43-86. doi: 10.1016/B978-0-12-385032-4.00002-1.

DOI:10.1016/B978-0-12-385032-4.00002-1
PMID:21040831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6171124/
Abstract

The hepatitis C virus (HCV) is a global public health problem affecting approximately 2% of the human population. The majority of HCV infections (more than 70%) result in life-long persistence of the virus that substantially increases the risk of serious liver diseases, including cirrhosis and hepatocellular carcinoma. The remainder (less than 30%) resolves spontaneously, often resulting in long-lived protection from persistence upon reexposure to the virus. To persist, the virus must replicate and this requires effective evasion of adaptive immune responses. In this review, the role of humoral and cellular immunity in preventing HCV persistence, and the mechanisms used by the virus to subvert protective host responses, are considered.

摘要

丙型肝炎病毒(HCV)是一个全球性的公共卫生问题,影响了大约 2%的人类人口。大多数 HCV 感染(超过 70%)导致病毒的终身持续存在,大大增加了患严重肝脏疾病的风险,包括肝硬化和肝细胞癌。其余(不到 30%)会自发解决,通常会在再次接触病毒时产生长期的保护作用,防止持续感染。为了持续存在,病毒必须复制,这需要有效地逃避适应性免疫反应。在这篇综述中,考虑了体液和细胞免疫在预防 HCV 持续感染中的作用,以及病毒用来颠覆宿主保护性反应的机制。

相似文献

1
Adaptive immunity to the hepatitis C virus.对丙型肝炎病毒的适应性免疫。
Adv Virus Res. 2010;78:43-86. doi: 10.1016/B978-0-12-385032-4.00002-1.
2
The role of chemokines in hepatitis C virus-mediated liver disease.趋化因子在丙型肝炎病毒介导的肝脏疾病中的作用。
Int J Mol Sci. 2014 Mar 18;15(3):4747-79. doi: 10.3390/ijms15034747.
3
Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.丙型肝炎病毒(HCV)采用多种策略来颠覆宿主的先天性抗病毒反应。
Biol Chem. 2008 Oct;389(10):1283-98. doi: 10.1515/BC.2008.147.
4
Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence.丙型肝炎病毒逃避特异性T细胞反应的策略:有利于其持续存在的一种可能机制。
Ann Hepatol. 2016 Jan-Feb;15(1):17-26. doi: 10.5604/16652681.1184193.
5
Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.马甲型肝炎病毒感染定义了独特的包膜高变区,并阐明了病毒株和适应性免疫状态在决定包膜多样性和感染结果中的潜在作用。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00314-18. Print 2018 Sep 15.
6
Hepatitis C virus--T-cell responses and viral escape mutations.丙型肝炎病毒——T 细胞反应和病毒逃逸突变。
Eur J Immunol. 2012 Jan;42(1):17-26. doi: 10.1002/eji.201141593. Epub 2011 Nov 28.
7
Current progress in host innate and adaptive immunity against hepatitis C virus infection.宿主针对丙型肝炎病毒感染的固有免疫和适应性免疫的当前进展。
Hepatol Int. 2017 Jul;11(4):374-383. doi: 10.1007/s12072-017-9805-2. Epub 2017 Jun 22.
8
Innate and adaptive immune responses in HCV infections.HCV 感染中的固有和适应性免疫反应。
J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3.
9
Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.丙型肝炎病毒操纵人类作为其长期关系的首选宿主。
Hepatology. 2019 Feb;69(2):889-900. doi: 10.1002/hep.30214.
10
Adaptive immune responses in hepatitis C virus infection.丙型肝炎病毒感染中的适应性免疫反应。
Curr Top Microbiol Immunol. 2013;369:243-62. doi: 10.1007/978-3-642-27340-7_10.

引用本文的文献

1
Design and nonviral delivery of live attenuated vaccine to prevent chronic hepatitis C virus-like infection.用于预防慢性丙型肝炎病毒样感染的减毒活疫苗的设计与非病毒递送
Nat Commun. 2025 Aug 15;16(1):7629. doi: 10.1038/s41467-025-62813-8.
2
Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection.在急性和慢性嗜肝病毒感染期间肝驻留 CD8 T 细胞的表型和命运。
PLoS Pathog. 2023 Oct 9;19(10):e1011697. doi: 10.1371/journal.ppat.1011697. eCollection 2023 Oct.
3
Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in Mice.

本文引用的文献

1
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.MF59 佐剂 HCV E1E2 疫苗在健康成年人中的安全性和免疫原性。
Vaccine. 2010 Aug 31;28(38):6367-73. doi: 10.1016/j.vaccine.2010.06.084. Epub 2010 Jul 7.
2
Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.丙型肝炎病毒适应小鼠 CD81 可在缺乏人进入因子的情况下感染小鼠细胞。
PLoS Pathog. 2010 Jul 1;6(7):e1000978. doi: 10.1371/journal.ppat.1000978.
3
FOXP3+ regulatory T cells in the human immune system.
巨噬细胞耗竭可在急性甲型肝炎小鼠痊愈后重新激活粪便病毒脱落。
J Virol. 2022 Dec 14;96(23):e0149622. doi: 10.1128/jvi.01496-22. Epub 2022 Nov 10.
4
Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.腺病毒载体 T 细胞疫苗对肝炎病毒的效力降低,针对大鼠的 CD8 T 细胞逃逸变异体。
PLoS Pathog. 2021 Mar 18;17(3):e1009391. doi: 10.1371/journal.ppat.1009391. eCollection 2021 Mar.
5
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design.构建结构表位模拟物:丙型肝炎病毒疫苗设计的独特型方法
NPJ Vaccines. 2021 Jan 8;6(1):7. doi: 10.1038/s41541-020-00269-1.
6
Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3.表达丙型肝炎病毒NS3的坏死性树突状细胞疫苗诱导的增强型T细胞反应
Front Microbiol. 2020 Nov 24;11:559105. doi: 10.3389/fmicb.2020.559105. eCollection 2020.
7
Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.持续复制的丙型肝炎样病毒对抗病毒 CD8 T 细胞的启动而无效应功能。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00035-20.
8
Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.接种疫苗以防止 T 细胞颠覆可以预防持续性肝肝炎病毒感染。
Nat Commun. 2019 Mar 7;10(1):1113. doi: 10.1038/s41467-019-09105-0.
9
Roles of hepatic stellate cells in liver inflammation: a new perspective.肝星状细胞在肝脏炎症中的作用:一个新视角。
Inflamm Regen. 2016 Apr 25;36:1. doi: 10.1186/s41232-016-0005-6. eCollection 2016.
10
The relationship between human leukocyte antigen-DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population.中国人群中人类白细胞抗原-DP/DQ 基因多态性与 HCV 感染结局的关系。
Virol J. 2017 Dec 6;14(1):235. doi: 10.1186/s12985-017-0901-7.
FOXP3+ 调节性 T 细胞在人类免疫系统中的作用。
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.
4
Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.PD-1、2B4、CD160 和 KLRG1 在耗竭的 HCV 特异性 CD8+ T 细胞上的共表达与抗原识别和 T 细胞分化有关。
PLoS Pathog. 2010 Jun 10;6(6):e1000947. doi: 10.1371/journal.ppat.1000947.
5
Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture.人源丙型肝炎病毒 1b 型分离株在细胞培养中持续生长。
PLoS Pathog. 2010 May 20;6(5):e1000910. doi: 10.1371/journal.ppat.1000910.
6
The resistance mutation R155K in the NS3/4A protease of hepatitis C virus also leads the virus to escape from HLA-A*68-restricted CD8 T cells.丙型肝炎病毒 NS3/4A 蛋白酶中的耐药突变 R155K 也导致病毒逃避 HLA-A*68 限制的 CD8 T 细胞。
Antiviral Res. 2010 Aug;87(2):272-5. doi: 10.1016/j.antiviral.2010.05.006. Epub 2010 May 19.
7
Claudin association with CD81 defines hepatitis C virus entry.Claudin 与 CD81 的结合定义了丙型肝炎病毒的进入。
J Biol Chem. 2010 Jul 2;285(27):21092-102. doi: 10.1074/jbc.M110.104836. Epub 2010 Apr 7.
8
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.丙型肝炎病毒高变区 1 调节受体相互作用,掩盖 CD81 结合位点,并保护保守的中和表位。
J Virol. 2010 Jun;84(11):5751-63. doi: 10.1128/JVI.02200-09. Epub 2010 Mar 31.
9
Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.丙型肝炎病毒 E2 糖蛋白保守区域内的突变影响病毒受体相互作用和对中和抗体的敏感性。
J Virol. 2010 Jun;84(11):5494-507. doi: 10.1128/JVI.02153-09. Epub 2010 Mar 17.
10
Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.核心特异性适应性调节 T 细胞在丙型肝炎不同结局中的作用。
Clin Sci (Lond). 2010 Apr 20;119(2):97-109. doi: 10.1042/CS20090661.